GoodRx Holdings Statistics
Total Valuation
GoodRx Holdings has a market cap or net worth of $1.31 billion. The enterprise value is $1.59 billion.
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GoodRx Holdings has 379.34 million shares outstanding. The number of shares has decreased by -4.46% in one year.
| Current Share Class | 102.47M |
| Shares Outstanding | 379.34M |
| Shares Change (YoY) | -4.46% |
| Shares Change (QoQ) | -5.93% |
| Owned by Insiders (%) | 3.25% |
| Owned by Institutions (%) | 21.21% |
| Float | 90.35M |
Valuation Ratios
The trailing PE ratio is 38.68 and the forward PE ratio is 21.70. GoodRx Holdings's PEG ratio is 1.31.
| PE Ratio | 38.68 |
| Forward PE | 21.70 |
| PS Ratio | 1.64 |
| Forward PS | 1.53 |
| PB Ratio | 1.91 |
| P/TBV Ratio | 75.61 |
| P/FCF Ratio | 6.97 |
| P/OCF Ratio | 6.93 |
| PEG Ratio | 1.31 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 12.18, with an EV/FCF ratio of 8.37.
| EV / Earnings | 45.85 |
| EV / Sales | 1.98 |
| EV / EBITDA | 12.18 |
| EV / EBIT | 14.54 |
| EV / FCF | 8.37 |
Financial Position
The company has a current ratio of 4.21, with a Debt / Equity ratio of 0.85.
| Current Ratio | 4.21 |
| Quick Ratio | 3.59 |
| Debt / Equity | 0.85 |
| Debt / EBITDA | 3.96 |
| Debt / FCF | 2.89 |
| Interest Coverage | 2.42 |
Financial Efficiency
Return on equity (ROE) is 5.27% and return on invested capital (ROIC) is 5.31%.
| Return on Equity (ROE) | 5.27% |
| Return on Assets (ROA) | 4.88% |
| Return on Invested Capital (ROIC) | 5.31% |
| Return on Capital Employed (ROCE) | 9.19% |
| Revenue Per Employee | $1.08M |
| Profits Per Employee | $46,883 |
| Employee Count | 738 |
| Asset Turnover | 0.57 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, GoodRx Holdings has paid $21.17 million in taxes.
| Income Tax | 21.17M |
| Effective Tax Rate | 37.96% |
Stock Price Statistics
The stock price has decreased by -51.53% in the last 52 weeks. The beta is 1.24, so GoodRx Holdings's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | -51.53% |
| 50-Day Moving Average | 4.56 |
| 200-Day Moving Average | 4.65 |
| Relative Strength Index (RSI) | 20.91 |
| Average Volume (20 Days) | 1,519,320 |
Short Selling Information
The latest short interest is 5.52 million, so 1.45% of the outstanding shares have been sold short.
| Short Interest | 5.52M |
| Short Previous Month | 5.30M |
| Short % of Shares Out | 1.45% |
| Short % of Float | 6.11% |
| Short Ratio (days to cover) | 3.51 |
Income Statement
In the last 12 months, GoodRx Holdings had revenue of $799.87 million and earned $34.60 million in profits. Earnings per share was $0.09.
| Revenue | 799.87M |
| Gross Profit | 749.28M |
| Operating Income | 109.13M |
| Pretax Income | -59.30M |
| Net Income | 34.60M |
| EBITDA | 130.21M |
| EBIT | 109.13M |
| Earnings Per Share (EPS) | $0.09 |
Full Income StatementBalance Sheet
The company has $281.32 million in cash and $547.54 million in debt, giving a net cash position of -$266.22 million or -$0.70 per share.
| Cash & Cash Equivalents | 281.32M |
| Total Debt | 547.54M |
| Net Cash | -266.22M |
| Net Cash Per Share | -$0.70 |
| Equity (Book Value) | 643.03M |
| Book Value Per Share | 1.82 |
| Working Capital | 419.71M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $190.60 million and capital expenditures -$1.10 million, giving a free cash flow of $189.50 million.
| Operating Cash Flow | 190.60M |
| Capital Expenditures | -1.10M |
| Free Cash Flow | 189.50M |
| FCF Per Share | $0.50 |
Full Cash Flow StatementMargins
Gross margin is 93.68%, with operating and profit margins of 13.64% and 4.33%.
| Gross Margin | 93.68% |
| Operating Margin | 13.64% |
| Pretax Margin | 6.97% |
| Profit Margin | 4.33% |
| EBITDA Margin | 16.28% |
| EBIT Margin | 13.64% |
| FCF Margin | 23.69% |
Dividends & Yields
GoodRx Holdings does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.46% |
| Shareholder Yield | 4.46% |
| Earnings Yield | 2.62% |
| FCF Yield | 14.36% |
Dividend DetailsAnalyst Forecast
The average price target for GoodRx Holdings is $6.33, which is 83.48% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.33 |
| Price Target Difference | 83.48% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 6.37% |
| EPS Growth Forecast (5Y) | 83.68% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |
